Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Zhongshi Duqing Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is particularly recognized for its focus on peptide-based drugs and biochemical products, maintaining significant manufacturing capacity for products like acarbose and various amino acid derivatives. Zhongshi Duqing operates with a strong emphasis on international quality standards, exporting its products to global markets including Europe, Southeast Asia, and the Americas. Their business model integrates R&D with high-volume chemical synthesis and fermentation-based manufacturing to serve both domestic and international healthcare needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhongshiduqing.